Generated by AI
Nutriband Inc. is a pharmaceutical company focused on the development of transdermal drug delivery products. The company’s core work centers on abuse-deterrent patch technologies designed to reduce the risk of misuse, diversion, and accidental exposure for drugs with abuse potential, particularly opioids. Its lead development program is AVERSA Fentanyl, alongside additional transdermal products such as AVERSA Buprenorphine and AVERSA Methylphenidate. Nutriband also operates through business segments that include pharmaceuticals and medical devices, supporting both product development and related manufacturing activities. Based in Orlando, Florida, Nutriband serves the healthcare market by advancing patch-based therapies that aim to deliver medications through the skin in a controlled and convenient format.
Website121 South Orange Avenue
Orlando, FL, 32801
United States
The latest articles about NTRB.
Summary of Sep 10's posts. Generated by AI.
Summary of Jul 2's posts. Generated by AI.
Summary of Sep 9's posts. Generated by AI.
Summary of Sep 10's posts. Generated by AI.
Investors talking about NTRB also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.